Im not sure if Rodne said that, but again theoretically phase 1 trials aren't enough proof of it being viable as a vaccine simply because it hasn't been tested in a huge number of trial participants. But I could be wrong, maybe 1 or 2% probability lol. Im assuming the full results will come and go, trading will resume as normal but naturally as we've seen with this stock, confirmation of a "pass mark" for phase 1 will be a confirmation to many to buy it.
It annoying to see sell offs from expectations not being met from inexperience.
Blue Sky, page-5
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.80 |
Change
-0.200(1.11%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $17.75 | $48.08K | 2.689K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14 | $17.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.91 | 32 | 2 |
View Market Depth
| Last trade - 14.38pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |